UPDATE: Morgan Stanley Reduces PT to $8.60 on Fibria Celulose; Q1 Miss, Balance Sheet
Morgan Stanley reduces its price target from $9.10 to $8.60 on Equal-weight-rated Fibria Celulose (NYSE: FBR) on Q1 miss and balance sheet concerns.
Morgan Stanley comments, "1Q12 EBITDA came below our estimate on the back of higher-than-expected cash costs. Management is working diligently to improve FBR's balance sheet, but ND/EBITDA remains elevated and it still poses a risk in the event that China's pulp imports slow down and, consequently, pulp prices decline."
FBR closed at $7.10 on Monday.
Latest Ratings for FBR
|Dec 2015||Goldman Sachs||Initiates Coverage on||Neutral|
|Aug 2015||JP MorganRR||Maintains||Neutral|
|Jul 2015||Morgan Stanley||Upgrades||Underweight||Equal-weight|
© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.